• Je něco špatně v tomto záznamu ?

The evaluation of formulations for the preparation of new formula pellets

J. Gajdziok, J. Bernatoniene, J. Muselík, R. Masteiková, K. Dvořáčková, Z. Petkeviciute, R. Lazauskas, Z. Kalveniene, R. Bernatoniene,

. 2011 ; 16 (5) : 520-528.

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12022543

The aim of the study was to prepare pellets of maidenhair tree (Ginkgo biloba), motherwort (Leonurus cardiaca) and hawthorn (Crataegus monogyna) dry extracts by extrusion/spheronization method. The critical step of this process was the amount of added wetting liquid (water-ethanolic mixture) and the amount of extract in the formulation. The samples of pellets containing 30-50% of extracts were formulated: Pellets contained extracts of Ginkgo, Crataegi and Leonuri. The last sample was aimed at the formulation of pellets with the content of 30% of the mixture of Ginkgo, Leonuri and Crataegi extracts in a ratio of 1:5:6. The remainder of the solid compounds in all formulations was microcrystalline cellulose (Avicel® PH-101). It was not possible to find a way to adequately wet the formulations with the content of extracts higher than 30% because of the unsuitable properties of all three extracts used. On the basis of the experiments, pellets with mixtures of all three previously used extracts were prepared. These pellets showed perfect physico-mechanical properties: Hardness (10.00 ± 2.24 N), friability (0.06%), repose angle (20.99 ± 0.41°), flowability (6.97 ± 0.29 s/100g of pellets), sphericity (0.81 ± 0.05), compressibility index (4.65%), intraparticular porosity (0.09%) and interparticular porosity (45.11%), which predetermine them to other testing and usage (feeling into capsules, tableting, coating etc.).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022543
003      
CZ-PrNML
005      
20170410094055.0
007      
ta
008      
120806s2011 xxk f 000 0#eng||
009      
AR
024    7_
$a 10.3109/10837450.2010.502174 $2 doi
035    __
$a (PubMed)20649408
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Gajdziok, Jan $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Czech Republic.
245    14
$a The evaluation of formulations for the preparation of new formula pellets / $c J. Gajdziok, J. Bernatoniene, J. Muselík, R. Masteiková, K. Dvořáčková, Z. Petkeviciute, R. Lazauskas, Z. Kalveniene, R. Bernatoniene,
520    9_
$a The aim of the study was to prepare pellets of maidenhair tree (Ginkgo biloba), motherwort (Leonurus cardiaca) and hawthorn (Crataegus monogyna) dry extracts by extrusion/spheronization method. The critical step of this process was the amount of added wetting liquid (water-ethanolic mixture) and the amount of extract in the formulation. The samples of pellets containing 30-50% of extracts were formulated: Pellets contained extracts of Ginkgo, Crataegi and Leonuri. The last sample was aimed at the formulation of pellets with the content of 30% of the mixture of Ginkgo, Leonuri and Crataegi extracts in a ratio of 1:5:6. The remainder of the solid compounds in all formulations was microcrystalline cellulose (Avicel® PH-101). It was not possible to find a way to adequately wet the formulations with the content of extracts higher than 30% because of the unsuitable properties of all three extracts used. On the basis of the experiments, pellets with mixtures of all three previously used extracts were prepared. These pellets showed perfect physico-mechanical properties: Hardness (10.00 ± 2.24 N), friability (0.06%), repose angle (20.99 ± 0.41°), flowability (6.97 ± 0.29 s/100g of pellets), sphericity (0.81 ± 0.05), compressibility index (4.65%), intraparticular porosity (0.09%) and interparticular porosity (45.11%), which predetermine them to other testing and usage (feeling into capsules, tableting, coating etc.).
650    _2
$a tobolky $x chemie $7 D002214
650    _2
$a celulosa $x chemie $7 D002482
650    _2
$a Crataegus $x chemie $7 D027825
650    _2
$a příprava léků $x metody $7 D004339
650    _2
$a pomocné látky $x chemie $7 D005079
650    _2
$a Ginkgo biloba $x chemie $7 D020441
650    _2
$a tvrdost $7 D006244
650    _2
$a srdečník $x chemie $7 D031332
650    _2
$a chemické jevy $7 D055598
650    _2
$a rostlinné extrakty $x chemie $7 D010936
650    _2
$a poréznost $7 D016062
650    _2
$a zvlhčující látky $x chemie $7 D014906
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bernatoniene, Jurga
700    1_
$a Muselík, Jan
700    1_
$a Masteiková, Ruta
700    1_
$a Dvořáčková, Kateřina
700    1_
$a Petkeviciute, Zivile
700    1_
$a Lazauskas, Robertas
700    1_
$a Kalveniene, Zenona
700    1_
$a Bernatoniene, Rūta
773    0_
$w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 16, č. 5 (2011), s. 520-528
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20649408 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120806 $b ABA008
991    __
$a 20170410094353 $b ABA008
999    __
$a ok $b bmc $g 944456 $s 779840
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 16 $c 5 $d 520-528 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
LZP    __
$a Pubmed-20120806/12/01

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...